mizuho's jared holz on novo nordisk: there's not much upside near-term
Published 1 year ago • 3.2K plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
3:43
mizuho's holz on weight loss drugs: lilly and novo nordisk are in excellent shape fundamentally
-
5:26
obesity drug supply-demand imbalance is working in novo nordisk's favor: mizuho's jared holz
-
6:21
novo nordisk falls after strong q1 results, mizuho's jared holz talks what's next for the company
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz
-
7:05
upside for emergent bio if they can get mpox vaccine rollout right, says mizuho's jared holz
-
16:33
founder stories: jan g. j. van de winkel, ceo of genmab
-
19:20
how ozempic and wegovy accidentally made novo nordisk a $400b company
-
24:07
the ceo behind ozempic, wegovy and europe's most valuable company
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
5:53
eli lilly and novo nordisk will remain leaders in the weight-loss drug market: mizuho's jared holz
-
5:12
structure therapeutics is a 'no-brainer takeout' target, says mizuho's jared holz
-
5:05
amgen has 'a lot to prove' in the weight-loss drug category, says mizuho's jared holz
-
5:09
biogen has been an 'uninvestable' stock for awhile, says mizuho's jared holz
-
5:53
mizuho's jared holz talks roche shares surging on glp-1 data
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
4:24
charting the next health care stocks to break out
-
3:15
mounjaro remains the single largest driver for eli lilly stock in the near term: mizuho's jared holz
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
3:52
novo and eli lilly stocks could go higher if they show even better data than we think: mizuho's holz
-
4:13
mizuho's jared holz on finding opportunities in the biotech space
-
2:34
here's why portfolio wealth advisors' lee munson is 'rooting' for zscaler
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz